Use of ofatumumab and eplerenone in post-transplant recurrence of FSGS.
Namarata G JainJustin K ChenRuchi Gupta MahajanJacqueline KehoePamela S SingerDilys WhyteAndrew S BombackPublished in: Pediatric transplantation (2021)
With notable risk of recurrence of FSGS in kidney transplants leading to allograft failure, the use of ofatumumab and eplerenone in conjunction should be considered for management to induce remission.